BeiGene, Ltd. (BGNE)
USD 184.71
(0.49%)
USD 184.71
(0.49%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 930.18 Million USD | 4.38% |
| 2022 | 891.12 Million USD | 28.29% |
| 2021 | 694.64 Million USD | 23.61% |
| 2020 | 561.96 Million USD | 102.62% |
| 2019 | 277.34 Million USD | 39.79% |
| 2018 | 198.4 Million USD | 20.45% |
| 2017 | 164.71 Million USD | 852.99% |
| 2016 | 17.28 Million USD | -16.85% |
| 2015 | 20.78 Million USD | 50.21% |
| 2014 | 13.83 Million USD | -49.43% |
| 2013 | 27.36 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 1.08 Billion USD | 2.53% |
| 2024 Q1 | 1.06 Billion USD | 14.29% |
| 2023 Q3 | 579.77 Million USD | -14.46% |
| 2023 Q4 | 930.18 Million USD | 60.44% |
| 2023 FY | 930.18 Million USD | 4.38% |
| 2023 Q1 | 545.19 Million USD | -38.82% |
| 2023 Q2 | 677.8 Million USD | 24.32% |
| 2022 Q3 | 710.57 Million USD | 12.32% |
| 2022 Q2 | 632.64 Million USD | -5.84% |
| 2022 Q1 | 671.87 Million USD | -3.28% |
| 2022 FY | 891.12 Million USD | 28.29% |
| 2022 Q4 | 891.12 Million USD | 25.41% |
| 2021 Q2 | 680.38 Million USD | 6.54% |
| 2021 Q4 | 694.64 Million USD | -0.7% |
| 2021 FY | 694.64 Million USD | 23.61% |
| 2021 Q1 | 638.62 Million USD | 13.64% |
| 2021 Q3 | 699.53 Million USD | 2.82% |
| 2020 Q1 | 298.05 Million USD | 7.47% |
| 2020 FY | 561.96 Million USD | 102.62% |
| 2020 Q4 | 561.96 Million USD | 130.57% |
| 2020 Q3 | 243.73 Million USD | -32.63% |
| 2020 Q2 | 361.76 Million USD | 21.38% |
| 2019 Q3 | 285.2 Million USD | 3.57% |
| 2019 Q4 | 277.34 Million USD | -2.76% |
| 2019 FY | 277.34 Million USD | 39.79% |
| 2019 Q1 | 270.59 Million USD | 36.39% |
| 2019 Q2 | 275.37 Million USD | 1.77% |
| 2018 Q1 | 173.68 Million USD | 5.44% |
| 2018 FY | 198.4 Million USD | 20.45% |
| 2018 Q4 | 198.4 Million USD | 1.24% |
| 2018 Q3 | 195.96 Million USD | -6.57% |
| 2018 Q2 | 209.75 Million USD | 20.77% |
| 2017 Q3 | 158.34 Million USD | 3.68% |
| 2017 Q1 | 19.9 Million USD | 15.16% |
| 2017 FY | 164.71 Million USD | 852.99% |
| 2017 Q4 | 164.71 Million USD | 4.02% |
| 2017 Q2 | 152.72 Million USD | 667.32% |
| 2016 FY | 17.28 Million USD | -16.85% |
| 2016 Q4 | 17.28 Million USD | -4.14% |
| 2016 Q2 | 10.55 Million USD | 69.83% |
| 2016 Q1 | 6.21 Million USD | -70.1% |
| 2016 Q3 | 18.03 Million USD | 70.85% |
| 2015 Q4 | 20.78 Million USD | 0.76% |
| 2015 Q2 | 14.04 Million USD | 0.0% |
| 2015 FY | 20.78 Million USD | 50.21% |
| 2015 Q1 | - USD | -100.0% |
| 2015 Q3 | 20.62 Million USD | 46.84% |
| 2014 Q4 | 13.83 Million USD | 0.0% |
| 2014 FY | 13.83 Million USD | -49.43% |
| 2013 FY | 27.36 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Agenus Inc. | 350.24 Million USD | -165.58% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -6339.94% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -3284.337% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -693.721% |
| MiMedx Group, Inc. | 48.09 Million USD | -1833.897% |
| Novavax, Inc. | 280.63 Million USD | -231.457% |
| Seer, Inc. | 28.25 Million USD | -3191.642% |
| Acelyrin, Inc. | 1.19 Million USD | -77804.941% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | -305.856% |
| IO Biotech, Inc. | 2.49 Million USD | -37196.913% |
| Ardelyx, Inc. | 55.98 Million USD | -1561.579% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -1210.563% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -4354.006% |
| Fortress Biotech, Inc. | 88.59 Million USD | -949.965% |
| Fortress Biotech, Inc. | 88.59 Million USD | -949.965% |
| Geron Corporation | 85.89 Million USD | -982.882% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -707.656% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -14081.811% |
| Incyte Corporation | 38.28 Million USD | -2329.506% |
| Innoviva, Inc. | 449.07 Million USD | -107.133% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| ChromaDex Corporation | 3.27 Million USD | -28285.261% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -14988.159% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| NextCure, Inc. | 6.6 Million USD | -13983.043% |
| Onconetix, Inc. | 9.88 Million USD | -9309.331% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -292411.006% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -114964.658% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -32288.057% |
| Vaxcyte, Inc. | 29.22 Million USD | -3082.949% |
| Precigen, Inc. | 7.09 Million USD | -13006.735% |
| Pharming Group N.V. | 171.54 Million USD | -442.24% |
| ContextLogic Inc. | 6 Million USD | -15403.083% |
| TRACON Pharmaceuticals, Inc. | 968 Thousand USD | -95993.492% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -4260.719% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -1435.491% |
| AlloVir, Inc. | 27.42 Million USD | -3291.246% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -742.88% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -321048.794% |
| Summit Therapeutics Inc. | 106.09 Million USD | -776.714% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -56792.049% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -14883.65% |
| Senti Biosciences, Inc. | 37.66 Million USD | -2369.561% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -817.487% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -1263.308% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -12047.535% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -2516.167% |
| Chimerix, Inc. | 2.14 Million USD | -43285.494% |
| PDS Biotechnology Corporation | 23.85 Million USD | -3799.882% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -5426.946% |
| CRISPR Therapeutics AG | 238.63 Million USD | -289.799% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -2796.149% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -569.053% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -3159.118% |
| Precision BioSciences, Inc. | 31.26 Million USD | -2874.878% |
| Dyadic International, Inc. | 136.92 Thousand USD | -679219.209% |
| Elevation Oncology, Inc. | 30.13 Million USD | -2986.522% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -16951.971% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -792.846% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 65.326% |
| Aptorum Group Limited | 3.36 Million USD | -27564.342% |
| Bicycle Therapeutics plc | 44.95 Million USD | -1969.101% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -920875.248% |
| Clearside Biomedical, Inc. | 43 Million USD | -2063.171% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -149446.706% |
| GT Biopharma, Inc. | 58 Thousand USD | -1603667.241% |
| Alkermes plc | 290.73 Million USD | -219.948% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -1943.913% |
| Jaguar Health, Inc. | 35.86 Million USD | -2493.935% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -43776.651% |
| AbCellera Biologics Inc. | 77.38 Million USD | -1102.1% |
| PureTech Health plc | 25.51 Million USD | -3546.069% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -206345.821% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -2341.174% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -102569.426% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -7068.504% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -13142.953% |
| AnaptysBio, Inc. | 17.81 Million USD | -5121.652% |
| eFFECTOR Therapeutics, Inc. | 19.44 Million USD | -4683.672% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -1157883.518% |
| Molecular Templates, Inc. | 12.23 Million USD | -7505.765% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Sorrento Therapeutics, Inc. | 134.5 Million USD | -591.567% |
| Vaxxinity, Inc. | 15.16 Million USD | -6032.549% |
| Viracta Therapeutics, Inc. | 25.55 Million USD | -3539.791% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -56172.535% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -3690.176% |
| Structure Therapeutics Inc. | 5.45 Million USD | -16958.222% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -195728.421% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -13509.144% |
| ImmuCell Corporation | 11.96 Million USD | -7671.422% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -396616.438% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -434565.888% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Opthea Limited | 200.62 Million USD | -363.635% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -9341.585% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -1398.486% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -798.417% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | -342.648% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -26050.829% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -55038.411% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -309225.472% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -3614.5% |
| Aptose Biosciences Inc. | 1 Million USD | -92015.218% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -10746029.852% |
| Soligenix, Inc. | 3.49 Million USD | -26518.079% |
| Century Therapeutics, Inc. | 48.17 Million USD | -1831.006% |
| Kura Oncology, Inc. | 17.2 Million USD | -5308.052% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -906.334% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -588624.684% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -43164.419% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -6556.541% |
| Autolus Therapeutics plc | 52.96 Million USD | -1656.159% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -16908.32% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -2123.036% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | -305.429% |
| GRI Bio, Inc. | 14 Thousand USD | -6644078.571% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -7387.001% |
| IGM Biosciences, Inc. | 40.5 Million USD | -2196.413% |
| INmune Bio, Inc. | 10.43 Million USD | -8812.379% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -417.84% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -15647.007% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -1138716.112% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -112398.246% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -1696.591% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -1496.035% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -1507.314% |
| Coherus BioSciences, Inc. | 480.84 Million USD | -93.449% |
| Verastem, Inc. | 41.55 Million USD | -2138.335% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -17125.648% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -8079.608% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -9379.109% |
| Histogen Inc. | 4.62 Million USD | -20025.162% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 3.37 Million USD | -27428.411% |
| Organovo Holdings, Inc. | 1.39 Million USD | -66627.762% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 46 Million USD | -1922.065% |
| Panbela Therapeutics, Inc. | 5.19 Million USD | -17808.837% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -4279.608% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -4356738.407% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -999.665% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -444922.007% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -2978.452% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -572966.9% |
| Apollomics, Inc. | 4.66 Million USD | -19856.769% |
| Amarin Corporation plc | 8.73 Million USD | -10546.503% |
| Mesoblast Limited | 118.92 Million USD | -682.174% |
| Turnstone Biologics Corp. | 3.21 Million USD | -28841.661% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -998.549% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -376493.117% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -852.99% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -389.715% |
| Better Therapeutics, Inc. | 14.88 Million USD | -6151.243% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -2938.43% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -738.548% |
| NLS Pharmaceutics AG | 1.63 Million USD | -56835.717% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 6.13 Million USD | -15074.307% |
| Gritstone bio, Inc. | 104.77 Million USD | -787.793% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -33287.832% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -1903286.536% |
| Avid Bioservices, Inc. | 207.83 Million USD | -347.562% |
| Insmed Incorporated | 1.2 Billion USD | 22.742% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.71 Million USD | -13760.602% |
| OmniAb, Inc. | 25.56 Million USD | -3539.079% |
| Alector, Inc. | 38.91 Million USD | -2290.115% |
| Seres Therapeutics, Inc. | 213.93 Million USD | -334.796% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 15.15 Million USD | -6039.43% |
| Revance Therapeutics, Inc. | 478.43 Million USD | -94.423% |
| Aura Biosciences, Inc. | 19.55 Million USD | -4656.277% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -1372.581% |
| Immunic, Inc. | 1.33 Million USD | -69629.01% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -2831.378% |
| Veracyte, Inc. | 12.63 Million USD | -7264.885% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | -44.245% |
| FibroGen, Inc. | 170.45 Million USD | -445.707% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -10143.2% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -456072.055% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 83.953% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -2513913.514% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -21853.859% |
| TG Therapeutics, Inc. | 110.79 Million USD | -739.555% |
| Galecto, Inc. | 249 Thousand USD | -373468.273% |
| Calithera Biosciences, Inc. | 1.66 Million USD | -55733.433% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 44.566% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -12612.655% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -17135.223% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -33287.832% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -3360.381% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -1963.73% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -65452.149% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -1956.294% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -2054.752% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -1828.684% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | -9.599% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -90437.941% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -8390.963% |
| NexImmune, Inc. | 68.8 Thousand USD | -1351736.242% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -6553267.62% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 65.586% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -237190.881% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -13369.23% |
| Ainos, Inc. | 5.96 Million USD | -15497.825% |
| Pluri Inc. | 29.61 Million USD | -3041.243% |
| Prothena Corporation plc | 11.83 Million USD | -7759.611% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -3586.091% |
| Celularity Inc. | 65.41 Million USD | -1321.932% |
| Rallybio Corporation | 392 Thousand USD | -237192.092% |
| Cue Biopharma, Inc. | 14.69 Million USD | -6229.942% |
| MeiraGTx Holdings plc | 89.26 Million USD | -942.061% |
| Omeros Corporation | 338.28 Million USD | -174.974% |
| Humacyte, Inc. | 58.1 Million USD | -1500.842% |
| Immunocore Holdings plc | 84.03 Million USD | -1006.941% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -50098.867% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -18972.893% |
| Blueprint Medicines Corporation | 774.12 Million USD | -20.16% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -18436.967% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -1404.715% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -793.584% |
| Pulmatrix, Inc. | 8.75 Million USD | -10523.401% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -13347.81% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -6616.137% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -706.43% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -2848.475% |
| Cytokinetics, Incorporated | 755.77 Million USD | -23.078% |
| Eloxx Pharmaceuticals, Inc. | 13.38 Million USD | -6849.978% |
| Nutriband Inc. | 241.28 Thousand USD | -385412.983% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -16914.542% |
| Vor Biopharma Inc. | 35.66 Million USD | -2508.483% |
| Roivant Sciences Ltd. | 499.74 Million USD | -86.13% |
| Evogene Ltd. | 1.13 Million USD | -81638.576% |
| ProKidney Corp. | 4.41 Million USD | -20978.291% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -75771.533% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -1686086.894% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 46.536% |
| CorMedix Inc. | 667.63 Thousand USD | -139226.006% |
| BioLineRx Ltd. | 11.59 Million USD | -7925.063% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -2289.992% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -1195.396% |
| Atai Life Sciences N.V. | 16.47 Million USD | -5545.697% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -37851.306% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -137705.185% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -1932.17% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -1430953.846% |
| MediciNova, Inc. | 215.92 Thousand USD | -430688.789% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -37181.964% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -73664.024% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -399.101% |
| Biomea Fusion, Inc. | 10.29 Million USD | -8934.431% |
| PTC Therapeutics, Inc. | 415.02 Million USD | -124.127% |
| Mereo BioPharma Group plc | 5.95 Million USD | -15528.108% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -25810.446% |
| Absci Corporation | 15.95 Million USD | -5729.323% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -10053.75% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -6240.297% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -3292.978% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -7488.391% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -7337.91% |
| Allakos Inc. | 41.46 Million USD | -2143.302% |
| Imunon, Inc. | 1.62 Million USD | -57152.23% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -8496.109% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -615916.556% |
| BioAtla, Inc. | 2.46 Million USD | -37712.398% |
| NLS Pharmaceutics AG | 1.63 Million USD | -56835.717% |
| Bio-Path Holdings, Inc. | 113 Thousand USD | -823072.566% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -877.897% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -16672.178% |
| XOMA Corporation | 124.45 Million USD | -647.437% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -4813.035% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -2054.852% |
| aTyr Pharma, Inc. | 15.09 Million USD | -6062.206% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -8251.454% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -3471.728% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -4319.351% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -266428.653% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -284801.973% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -56906.236% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 37.957% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -567200.127% |
| UroGen Pharma Ltd. | 100.21 Million USD | -828.199% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -408.996% |
| ZIVO Bioscience, Inc. | 346.34 Thousand USD | -268474.126% |
| Orgenesis Inc. | 22.62 Million USD | -4012.042% |
| Entera Bio Ltd. | 390 Thousand USD | -238408.974% |
| GH Research PLC | 343 Thousand USD | -271090.962% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -304878.689% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -95499.692% |
| Xencor, Inc. | 83.43 Million USD | -1014.875% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -538597.422% |
| Replimune Group, Inc. | 75.86 Million USD | -1126.041% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -75881.477% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -9791.376% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -567200.127% |
| Portage Biotech Inc. | 47 Thousand USD | -1979017.021% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -73664.024% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -38385.106% |
| OncoCyte Corporation | 2.86 Million USD | -32321.924% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -71495.87% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -617741.439% |
| Purple Biotech Ltd. | 351 Thousand USD | -264909.972% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -29345.552% |
| scPharmaceuticals Inc. | 40.26 Million USD | -2209.928% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 51.19 Million USD | -1717.016% |
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -654959.859% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -17682.164% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -3378.888% |
| Curis, Inc. | 2.79 Million USD | -33192.233% |
| Daré Bioscience, Inc. | 5.31 Million USD | -17390.779% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -43438.835% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -164534.513% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -5459.65% |
| Kiromic BioPharma, Inc. | 15.54 Million USD | -5884.784% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -957.701% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -81423.663% |
| Erasca, Inc. | 55.85 Million USD | -1565.237% |
| bluebird bio, Inc. | 330.32 Million USD | -181.596% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 17.964% |
| DBV Technologies S.A. | 14.38 Million USD | -6368.152% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -37077.658% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -19929.823% |
| Travere Therapeutics, Inc. | 404.78 Million USD | -129.798% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -1920.428% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -20081.927% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -36492.644% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -4833.883% |
| MacroGenics, Inc. | 33.97 Million USD | -2638.174% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 20.92 Million USD | -4345.541% |
| Prime Medicine, Inc. | 13.63 Million USD | -6723.04% |
| Aditxt, Inc. | 18.21 Million USD | -5005.86% |
| Adagene Inc. | 22.3 Million USD | -4069.948% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -5978.449% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | -52.248% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -4483.773% |
| SciSparc Ltd. | 76 Thousand USD | -1223827.632% |
| Vericel Corporation | 88.14 Million USD | -955.314% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -1034.139% |
| Generation Bio Co. | 97.89 Million USD | -850.196% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -282631.003% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -3576.911% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -351.73% |
| Invivyd, Inc. | 2.16 Million USD | -42864.665% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -1639.769% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -26397637.625% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -16681.256% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -1476384.127% |
| 2seventy bio, Inc. | 256.67 Million USD | -262.401% |
| ADMA Biologics, Inc. | 141.41 Million USD | -557.756% |
| Clene Inc. | 32.16 Million USD | -2792.276% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -16474.474% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -42277.449% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -1735.698% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -193187.203% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -381.482% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 30.12 Million USD | -2987.649% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -5308.996% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -646.897% |
| Evaxion Biotech A/S | 10.86 Million USD | -8457.612% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -1015.477% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -1141.786% |
| Trevena, Inc. | 35.23 Million USD | -2540.096% |
| Surrozen, Inc. | 3.37 Million USD | -27428.411% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -14219.35% |
| Cingulate Inc. | 3.13 Million USD | -29570.036% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -2268643.902% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -3346.406% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -185601.623% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -154159.536% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -1526.055% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -199939.785% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 28.27 Million USD | -3190.128% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -4500.549% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -59718.971% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -73724.206% |
| Statera Biopharma, Inc. | 16.26 Million USD | -5620.295% |
| ImmunityBio, Inc. | 883.67 Million USD | -5.263% |
| Korro Bio, Inc. | 33.2 Million USD | -2701.171% |
| Kineta, Inc. | 1.31 Million USD | -70529.081% |
| BioVie Inc. | 6.11 Million USD | -15120.373% |
| Codexis, Inc. | 22.36 Million USD | -4059.296% |
| Celularity Inc. | 65.41 Million USD | -1321.932% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -1698.223% |
| Celcuity Inc. | 37.44 Million USD | -2384.052% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -414605.751% |
| Cibus, Inc. | 24.62 Million USD | -3678.015% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -242768.146% |
| IN8bio, Inc. | 4.89 Million USD | -18910.525% |
| Kodiak Sciences Inc. | 181.63 Million USD | -412.126% |
| Annexon, Inc. | 31.35 Million USD | -2866.624% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -1139.652% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -39617.549% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -23732.565% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 36.006% |
| Eyenovia, Inc. | 16.1 Million USD | -5674.764% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -734.321% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -94335.025% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -8018.923% |
| Arcellx, Inc. | 97.62 Million USD | -852.814% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -43184.551% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -3408.411% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -29886.622% |
| Moolec Science SA | 2.64 Million USD | -35063.833% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -3165.296% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -14634.437% |
| Royalty Pharma plc | 6.13 Billion USD | 84.839% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -38625.437% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -806973.941% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -2649.586% |
| Humacyte, Inc. | 58.1 Million USD | -1500.842% |
| 89bio, Inc. | 27.1 Million USD | -3331.404% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -6901.242% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -36826.757% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -69420.553% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -777.004% |
| Notable Labs, Ltd. | 2.04 Million USD | -45297.023% |
| Liquidia Corporation | 3.5 Million USD | -26453.954% |
| Mustang Bio, Inc. | 2.49 Million USD | -37137.19% |
| Immunovant, Inc. | 138 Thousand USD | -673947.101% |
| Quantum-Si incorporated | 15.3 Million USD | -5978.449% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -10566.036% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -232446.25% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -1631.93% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -1138716.112% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -8431.459% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -441816.205% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -458119.212% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -4402.13% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -230715.136% |
| PepGen Inc. | 20.1 Million USD | -4526.865% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -161953.136% |
| United Therapeutics Corporation | 700 Million USD | -32.884% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 26.26 Million USD | -3441.538% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.46 Million USD | -20742.338% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 886 Thousand USD | -104887.02% |
| XOMA Corporation | 124.45 Million USD | -647.437% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -339383.577% |
| Bionomics Limited | 239.61 Million USD | -288.195% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -45631.832% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -6906.516% |
| uniQure N.V. | 138.4 Million USD | -572.055% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -988.916% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -90034.205% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -94335.025% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -10143.2% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -53144.705% |
| Altimmune, Inc. | 671 Thousand USD | -138526.677% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | -109.003% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -6906.516% |
| Compugen Ltd. | 1.35 Million USD | -68751.591% |
| Peak Bio, Inc. | 10.72 Million USD | -8575.636% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -2075.057% |
| Benitec Biopharma Inc. | 284 Thousand USD | -327429.93% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -1000.095% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -4569.369% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 11.77 Million USD | -7796.978% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -917.062% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -4569.369% |
| Instil Bio, Inc. | 86.05 Million USD | -980.932% |
| argenx SE | 20 Million USD | -4550.925% |
| Immunome, Inc. | 1.65 Million USD | -56274.848% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -53574.841% |
| Verona Pharma plc | 51.32 Million USD | -1712.202% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -9413.039% |
| Shattuck Labs, Inc. | 4.2 Million USD | -22036.721% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -256857.182% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -22147.907% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -158905.983% |
| Moolec Science SA | 2.64 Million USD | -35063.833% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -2979.14% |
| Design Therapeutics, Inc. | 3.05 Million USD | -30397.869% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -354932.443% |
| NeurAxis, Inc. | 224.26 Thousand USD | -414679.72% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -6437.707% |
| Lumos Pharma, Inc. | 6.58 Million USD | -14025.816% |
| Achilles Therapeutics plc | 4.61 Million USD | -20055.688% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -9413.039% |
| 180 Life Sciences Corp. | 1.32 Million USD | -70364.877% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -5346.009% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -59718.971% |
| Nutriband Inc. | 241.28 Thousand USD | -385412.983% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -9007.853% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -112513.196% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | -148.898% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -2990.418% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -25054.643% |
| Palisade Bio, Inc. | 369 Thousand USD | -251982.656% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -224040.964% |
| Beam Therapeutics Inc. | 173.17 Million USD | -437.142% |
| Neurogene Inc. | 16.25 Million USD | -5622.455% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | -201.869% |
| AEON Biopharma, Inc. | 278 Thousand USD | -334498.921% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -277567.164% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -870118.26% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -1126.154% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -1422.223% |
| Athira Pharma, Inc. | 1.58 Million USD | -58586.751% |
| Vaccinex, Inc. | 247 Thousand USD | -376493.117% |
| HCW Biologics Inc. | 6.45 Million USD | -14317.501% |
| XOMA Corporation | 124.45 Million USD | -647.437% |
| Nektar Therapeutics | 230.4 Million USD | -303.724% |
| Arvinas, Inc. | 3.4 Million USD | -27258.382% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -56906.236% |
| Merus N.V. | 12.16 Million USD | -7548.29% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -624.285% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -6633.64% |
| Rezolute, Inc. | 2.22 Million USD | -41649.776% |
| Clene Inc. | 32.16 Million USD | -2792.276% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -531273.355% |
| BeyondSpring Inc. | 3.99 Million USD | -23183.73% |
| Synlogic, Inc. | 17.27 Million USD | -5284.573% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -71452.692% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -2657571.429% |
| Peak Bio, Inc. | 10.72 Million USD | -8575.636% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -1691.47% |
| Krystal Biotech, Inc. | 8.09 Million USD | -11392.28% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -425.481% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -13081.026% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -680885.256% |
| MannKind Corporation | 382.37 Million USD | -143.263% |
| Ikena Oncology, Inc. | 10.73 Million USD | -8562.554% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -227329.095% |
| Gossamer Bio, Inc. | 212.46 Million USD | -337.808% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -534489.08% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -10053.75% |
| Legend Biotech Corporation | 328.67 Million USD | -183.013% |
| Mural Oncology plc | 15 Million USD | -6097.515% |
| Biora Therapeutics, Inc. | 47.42 Million USD | -1861.34% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 2.1 Million USD | -44173.441% |
| Champions Oncology, Inc. | 7.43 Million USD | -12419.314% |
| REGENXBIO Inc. | 89.29 Million USD | -941.757% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -108732.136% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -168112.528% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -17081.105% |
| Vaxart, Inc. | 26.51 Million USD | -3408.279% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -5840.88% |
| Cellectis S.A. | 92.85 Million USD | -901.782% |
| Longeveron Inc. | 2.04 Million USD | -45474.963% |
| Repare Therapeutics Inc. | 3.41 Million USD | -27178.152% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 33.406% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -1896.448% |
| Revolution Medicines, Inc. | 87.94 Million USD | -957.701% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -537579.191% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -23431.116% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -293333.754% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -531434.286% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | -15.065% |
| Denali Therapeutics Inc. | 52.24 Million USD | -1680.565% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -6357.168% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -67599.054% |
| Cingulate Inc. | 3.13 Million USD | -29570.036% |
| Passage Bio, Inc. | 26.29 Million USD | -3437.632% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -13856.264% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -227886.52% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -103947.539% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -4424.026% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -73724.206% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -37849.371% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -29684.982% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -114596.054% |
| OmniAb, Inc. | 25.56 Million USD | -3539.079% |
| Anew Medical, Inc. | 1.6 Million USD | -57855.452% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -3044.337% |
| Lipocine Inc. | 17.16 Thousand USD | -5418663.835% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -7892.653% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -2586.222% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -15647.007% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -1526.966% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -458119.212% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -17909.39% |
| Ocugen, Inc. | 6.94 Million USD | -13301.311% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -6483.516% |
| Q32 Bio Inc. | 1.31 Million USD | -70475.493% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -138320.387% |
| Alumis Inc. Common Stock | 32.58 Million USD | -2755.08% |
| Equillium, Inc. | 824 Thousand USD | -112786.529% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -10145.457% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -309130.866% |
| Galera Therapeutics, Inc. | 152.29 Million USD | -510.762% |
| Evelo Biosciences, Inc. | 51.13 Million USD | -1718.97% |
| Comera Life Sciences Holdings, Inc. | 775.04 Thousand USD | -119916.438% |
| Dominari Holdings Inc. | 3.02 Million USD | -30619.452% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -984358.179% |
| vTv Therapeutics Inc. | 529 Thousand USD | -175738.374% |
| Bio-Techne Corporation | 419.53 Million USD | -121.717% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -1191.995% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -380.552% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -5407.964% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -3986.57% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -15254.655% |
| Nkarta, Inc. | 88.33 Million USD | -952.972% |
| BioCardia, Inc. | 1.31 Million USD | -70636.502% |
| Iterum Therapeutics plc | 19.5 Million USD | -4667.979% |